Browse by UCL people
Group by: Type | Date
Jump to: Article | Conference item
Number of items: 8.
Article
Attard, G;
Murphy, L;
Clarke, NW;
Sachdeva, A;
Jones, C;
Hoyle, A;
Cross, W;
... McPhail, N; + view all
(2023)
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol.
The Lancet Oncology
, 24
(5)
pp. 443-456.
10.1016/S1470-2045(23)00148-1.
|
Gray, Emma;
Amjad, Anneesa;
Robertson, Jenny;
Beveridge, Judy;
Scott, Susan;
Peryer, Guy;
Braisher, Marie;
... Chataway, Jeremy; + view all
(2023)
Enhancing involvement of people with multiple sclerosis in clinical trial design.
Multiple Sclerosis Journal
, 29
(9)
pp. 1162-1173.
10.1177/13524585231189678.
|
Mulvenna, P;
Nankivell, M;
Barton, R;
Faivre-Finn, C;
Wilson, P;
McColl, E;
Moore, B;
... Langley, RE; + view all
(2016)
Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial.
Lancet
, 388
(10055)
pp. 2004-2014.
10.1016/S0140-6736(16)30825-X.
|
Parker, CC;
Clarke, NW;
Cook, AD;
Petersen, PM;
Catton, CN;
Cross, WR;
Kynaston, H;
... Sydes, MR; + view all
(2024)
Randomised Trial of No, Short-term, or Long-term Androgen Deprivation Therapy with Postoperative Radiotherapy After Radical Prostatectomy: Results from the Three-way Comparison of RADICALS-HD (NCT00541047).
European Urology
10.1016/j.eururo.2024.07.026.
(In press).
|
Parker, CC;
Petersen, PM;
Cook, AD;
Clarke, NW;
Catton, C;
Cross, WR;
Kynaston, H;
... Sydes, MR; + view all
(2024)
Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047).
Annals of Oncology
, 35
(7)
pp. 656-666.
10.1016/j.annonc.2024.03.010.
|
Schiavone, F;
Bathia, R;
Letchmanan, K;
Masters, L;
Amos, C;
Bara, A;
Brown, L;
... Sydes, MR; + view all
(2019)
This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols.
Trials
, 20
, Article 264. 10.1186/s13063-019-3216-8.
|
Wasan, H;
Meade, AM;
Adams, R;
Wilson, R;
Pugh, C;
Fisher, D;
Sydes, B;
... on behalf of the COIN-B investigators; + view all
(2014)
Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial.
Lancet Oncology
, 15
(6)
pp. 631-639.
10.1016/S1470-2045(14)70106-8.
|
Conference item
Nicholas, Richard;
Knowles, Sarah;
Drescher, Sonja;
Craig, Elaine;
Pugh, Cheryl;
Braisher, Marie;
Tallantyre, Emma;
... Middleton, Rod; + view all
(2024)
The external validity of the multi-arm multi-stage OCTOPUS trial in progressive MS: recruitment phase.
Presented at: 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Denmark.
|